Assessing fatal cardiovascular disease risk with the SCORE (Systematic Coronary Risk Evaluation) scale in post-menopausal women 10 years after different hormone treatment regimens

References

• Marín A, Medrano MJ, González J, Pintado H, Compaired V, Bárcena M, Fustero MV, Tisaire J, Cucalón JM, Martín A, et al. Risk of ischaemic heart disease and acute myocardial infarction in a Spanish population: observational prospective study in a primary-care setting. BMC Public Health 2006;6:38.
   PubMedGoogle Scholar
• Rees M, Stevenson J, British Menopause Society Council. Primary prevention of coronary heart disease in women. Menopause Int 2008;14:40–45.
   PubMedGoogle Scholar
• Stevenson JC. HRT and cardiovascular disease. Best Pract Res Clin Obstet Gynaecol 2009;23:109–120.
   PubMed Web of Science ®Google Scholar
• Cardiovascular Research Foundation. Signs of heart disease are attributed to stress more frequently in women than men. http://www.sciencedaily.com/releases/2008/10/081012121314.htm. Last accessed 10 April 2009.
   Google Scholar
• Akhter N, Milford-Beland S, Roe MT, Piana RN, Kao J, Shroff A. Gender differences among patients with acute coronary syndromes undergoing percutaneous coronary intervention in the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR). Am Heart J 2009;157:141–148.
   PubMed Web of Science ®Google Scholar
• Lenfant C, Friedman L, Thom T. Fifty years of death certificates: the Framingham Heart Study. Ann Intern Med 1998;129:1066–1067.
   PubMedGoogle Scholar
• Wilson PWF, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998;97:1837–1847.
   PubMed Web of Science ®Google Scholar
• Mann J, Crooke M, Fear H, Hay DR, Jackson RT, Neutze JM, White HD. Guidelines for detection and management of dyslipidaemia. Scientific Committee of the National Heart Foundation of New Zealand. N Z Med J 1993;106:133–141.
   PubMed Web of Science ®Google Scholar
• NCEP Expert Panel. Detection, evaluation and treatment of high blood cholesterol in adults (adult treatment panel III): executive summary 3, 1–30. Report of the national cholesterol education program (NCEP) Bethesda, MD: National Institute of Health/National Heart, Lung and Blood Institute; 2001.
   Google Scholar
• Department of Health. National service framework for coronary heart disease London: DoH; 2000.
   Google Scholar
• Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, Dallongeville J, De Backer G, Ebrahim S, Gjelsvik B, et al. Task Force Members. European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts). Eur Heart J 2007;28:2375–2414.
   PubMed Web of Science ®Google Scholar
• Pyorala K, De Backer G, Graham I, Poole-Wilson P, Wood D. Prevention of coronary heart disease in clinical practice: recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and the European Society of Hypertension. Atherosclerosis 1994;110:121–161.
   PubMedGoogle Scholar
• Wood D, De Backer G, Faergeman O, Graham I, Mancia G, Pyorala K. Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and Other Societies on coronary prevention. Eur Heart J 1998;19:1434–1503.
   PubMed Web of Science ®Google Scholar
• Ducimetiere P, Richard JL, Cambien F, Rakotovao R, Claude JR. Coronary heart disease in middle-aged Frenchmen. Comparisons between Paris Prospective Study, Seven Countries Study, and Pooling Project. Lancet 1980;1:1346–1350.
   PubMedGoogle Scholar
• Conroy RM, Pyörälä K, Fitzgerald AP, Sans S, Menotti A, De Backer G, De Bacquer D, Ducimetière P, Jousilahti P, Keil U, et al. SCORE project group. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003;24:987–1003.
   PubMed Web of Science ®Google Scholar
• Brindle P, Beswick A, Fahey T, Ebrahim S. Accuracy and impact of risk assessment in the primary prevention of cardiovascular disease: a systematic review. Heart 2006;92:1752–1759.
   PubMed Web of Science ®Google Scholar
• Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, May M, Brindle P. Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study. BMJ 2007;335:136.
   PubMed Web of Science ®Google Scholar
• Lobo RA. Evaluation of cardiovascular event rates with hormone therapy in healthy, early postmenopausal women: results from 2 large clinical trials. Arch Intern Med 2004;164:482–484.
   PubMed Web of Science ®Google Scholar
• The SCORE calculator. http://www.escardio.org/guidelines-surveys/esc-guidelines/Pages/cvd-prevention.aspx. Last accessed 20 February 2009.
   Google Scholar
• Sans S, Kesteloot H, Kromhout D. Task Force of the European Society of Cardiology on Cardiovascular Mortality and Morbidity Statistics in Europe. The burden of cardiovascular diseases mortality in Europe. Eur Heart J 1997;18:1231–1248.
   Web of Science ®Google Scholar
• Müller-Nordhorn J, Rossnagel K, Mey W, Willich SN. Regional variation and time trends in mortality from ischaemic heart disease: East and West Germany 10 years after reunification. J Epidemiol Community Health 2004;58:481–485.
   PubMedGoogle Scholar
• Müller-Nordhorn J, Binting S, Roll S, Willich SN. An update on regional variation in cardiovascular mortality within Europe. Eur Heart J 2008; 29:1316–1326.
   PubMed Web of Science ®Google Scholar
• Instituto Nacional de Estadística. Defunciones según la Causa de Muerte 2006 Tablas Nacionales. Defunciones por causas, sexo y edad http://www.ine.es/jaxi/tabla.do. Last accessed 20 April 2009.
   Google Scholar
• Burke GL, Bertoni AG, Shea S, Tracy R, Watson KE, Blumenthal RS, Chung H, Carnethon MR. The impact of obesity on cardiovascular disease risk factors and subclinical vascular disease: the Multi-Ethnic Study of Atherosclerosis. Arch Intern Med 2008;168:928–935.
   PubMed Web of Science ®Google Scholar
• Lobo RA. Metabolic syndrome after menopause and the role of hormones. Maturitas 2008;60:10–18.
   PubMed Web of Science ®Google Scholar
• Hroussalas G, Kassi E, Dalamaga M, Delimaris I, Zachari A, Dionyssiou-Asteriou A. Leptin, soluble leptin receptor, adiponectin and resistin in relation to OGTT in overweight/obese postmenopausal women. Maturitas 2008;59:339–349.
   PubMed Web of Science ®Google Scholar
• Rivera CM, Grossardt BR, Rhodes DJ, Brown RD Jr, Roger VL, Melton LJ III, Rocca WA. Increased cardiovascular mortality after early bilateral oophorectomy. Menopause 2009;16:15–23.
   PubMed Web of Science ®Google Scholar
• The Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principles results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321–333.
   PubMed Web of Science ®Google Scholar
• The Women's Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy. The Women's Health Initiative randomized controlled trial. JAMA 2004;291:1701–1712.
   PubMed Web of Science ®Google Scholar
• Naftolin F, Taylor HS, Karas R, Brinton E, Newman I, Clarkson TB, Mendelsohn M, Lobo RA, Judelson DR, Nachtigall LE, et al. Women's Health Initiative. The Women's Health Initiative could not have detected cardioprotective effects of starting hormone therapy during the menopausal transition. Fertil Steril 2004;81:1498–1501.
   PubMed Web of Science ®Google Scholar
• Pérez-López FR. Vitamin D metabolism and cardiovascular risk factors in postmenopausal women. Maturitas 2009;62:248–262.
   PubMed Web of Science ®Google Scholar
• Pérez-López FR, Chedraui P, Haya J, Cuadros JL. Effects of the Mediterranean diet pattern on longevity and age-prevalent morbid conditions. Maturitas 2009;64:67–79.
   PubMed Web of Science ®Google Scholar
• Beral V, Million Women Study Collaborators. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003;362:419–427.
   PubMed Web of Science ®Google Scholar
• Gompel A, Rozenberg S, Barlow DH, EMAS board members. The EMAS 2008 update on clinical recommendations on postmenopausal hormone replacement therapy. Maturitas 2008;61:227–232.
   PubMed Web of Science ®Google Scholar
• Hemelaar M, van der Mooren MJ, Rad M, Kluft C, Kenemans P. Effects of non-oral postmenopausal hormone therapy on markers of cardiovascular risk: a systematic review. Fertil Steril 2008;90:642–672.
   PubMed Web of Science ®Google Scholar
• Canonico M, Plu-Bureau G, Lowe GDO, Scarabin PY. Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis. BMJ 2008;336:1227–1231.
   PubMed Web of Science ®Google Scholar
• Eilertsen AL, Høibraaten E, Os I, Andersen TO, Sandvik L, Sandset PM. The effects of oral and transdermal hormone replacement therapy on C-reactive protein levels and other inflammatory markers in women with high risk of thrombosis. Maturitas 2005;52:111–118.
   PubMed Web of Science ®Google Scholar
• Brosnan JF, Sheppard BL, Norris LA. Haemostatic activation in post-menopausal women taking low-dose hormone therapy: less effect with transdermal administration?. Thromb Haemost 2007;97:558–565.
   PubMed Web of Science ®Google Scholar
• Sare GM, Gray LJ, Bath PMW. Association between hormone replacement therapy and subsequent arterial and venous vascular events: a meta analysis. Eur Heart J 2008;29:2031–2041.
   PubMed Web of Science ®Google Scholar
• Pérez-López FR, Chedraui P, Gilbert JJ, Pérez Roncero G. Modern Trend. Cardiovascular risk in menopausal women and prevalent related co-morbid conditions: facing the post-WHI era. Fertil Steril 2009;92:1171–1186.
   PubMed Web of Science ®Google Scholar
• Aspelund T, Thorgeirsson G, Sigurdsson G, Gudnason V. Estimation of 10-year risk of fatal cardiovascular disease and coronary heart disease in Iceland with results comparable with those of the Systematic Coronary Risk Evaluation project. Eur J Cardiovasc Prev Rehabil 2007;14:761–768.
   PubMedGoogle Scholar